Mechanism of Inhibition of the Class C β-Lactamase of Enterobacter c loacae P99 by Cyclic Acyl Phosph(on)ates:  Rescue by Return

As previously described (Pratt, R. F.; Hammar, N. J. J. Am. Chem. Soc. 1998, 120, 3004.), 1-hydroxy-4,5-benzo-2,6-dioxaphosphorinone(3)-1-oxide (salicyloyl cyclic phosphate) inactivates the class C β-lactamase of Enterobacter cloacae P99 in a covalent fashion. The inactivated enzyme slowly reverts t...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Chemical Society Vol. 123; no. 43; pp. 10436 - 10443
Main Authors Kaur, Kamaljit, Lan, Martin J. K, Pratt, R. F
Format Journal Article
LanguageEnglish
Published American Chemical Society 31.10.2001
Online AccessGet full text

Cover

Loading…
More Information
Summary:As previously described (Pratt, R. F.; Hammar, N. J. J. Am. Chem. Soc. 1998, 120, 3004.), 1-hydroxy-4,5-benzo-2,6-dioxaphosphorinone(3)-1-oxide (salicyloyl cyclic phosphate) inactivates the class C β-lactamase of Enterobacter cloacae P99 in a covalent fashion. The inactivated enzyme slowly reverts to the active form. This paper shows that reactivation involves a recyclization reaction that regenerates salicyloyl cyclic phosphate rather than hydrolysis of the covalent intermediate. The inactivation, therefore, is a slowly reversible covalent modification of the active site. The thermodynamic dissociation constant of the inhibitor from the inactivated enzyme is 0.16 μM. Treatment of the inactivated enzyme with alkali does not produce salicylic acid but does, after subsequent acid hydrolysis, yield one molar equivalent of lysinoalanine. This result proves that salicyloyl cyclic phosphate inactivates the enzyme by (slowly reversible) phosphorylation of the active site serine residue. This result contrasts sharply with the behavior of acyclic acyl phosphates which transiently inactivate the P99 β-lactamase by acylation (Li, N.; Pratt, R. F. J. Am. Chem. Soc. 1998, 120, 4264.). This chemoselectivity difference is explored by means of molecular modeling. Rather counterintuitively, in view of the relative susceptibility of phosphates and phosphonates to nucleophilic attack at phosphorus, 1-hydroxy-4,5-benzo-2-oxaphosphorinanone(3)-1-oxide, the phosphonate analogue of salicyloyl cyclic phosphate, did not appear to inactivate the P99 β-lactamase in a time-dependent fashion. It was found, however, to act as a fast reversible inhibitor (K i = 10 μM). A closer examination of the kinetics of inhibition revealed that both on and off rates (9.8 × 103 s-1 M-1 and 0.098 s-1, respectively) were much slower than expected for noncovalent binding. This result strongly indicates that the inhibition reaction of the phosphonate also involves phosphylation of the active site. Hence, unlike the situation with bacterial DD-peptidases covalently inactivated by β-lactams, the P99 β-lactamase inactivated by the above cyclic acyl phosph(on)ates can be rescued by return. Elimination of the recyclization reaction would lead to more effective inhibitors.
ISSN:0002-7863
1520-5126
DOI:10.1021/ja011094v